0001144204-17-021384.txt : 20170420 0001144204-17-021384.hdr.sgml : 20170420 20170420211728 ACCESSION NUMBER: 0001144204-17-021384 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170419 FILED AS OF DATE: 20170420 DATE AS OF CHANGE: 20170420 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLx Pharma Inc. CENTRAL INDEX KEY: 0001497504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271707962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: (713) 842-1249 MAIL ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20140313 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC DATE OF NAME CHANGE: 20100726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valentino Michael J CENTRAL INDEX KEY: 0001319551 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36351 FILM NUMBER: 17774031 MAIL ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 4 1 v464782_4.xml OWNERSHIP DOCUMENT X0306 4 2017-04-19 0 0001497504 PLx Pharma Inc. PLXP 0001319551 Valentino Michael J 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 1 1 0 0 Executive Chairman Common Stock 2017-04-19 4 A 0 93295 A 93295 D Options 12.44 2017-04-19 4 A 0 112509 0 A 2025-07-22 Common Stock 112509 112509 D Received in exchange for 118,461 shares of common stock of PLx Opco Inc. (formerly PLx Pharma Inc.) in connection with the merger (the "Merger") of PLx Opco Inc. with a wholly owned subsidiary of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.). Received in connection with the Merger in exchange for an employee stock option to buy 142,857 shares of PLx Opco Inc. common stock for $9.80 per share. The option is exercisable as to 60,005 shares as of the date hereof, and will become exercisable as to an additional 26,252 shares on each of July 22, 2017 and July 22, 2018 (generally subject to continued employment or consulting relationship through such date). /s/ David E. Jorden, David E. Jorden, as Attorney-in-Fact for Michael J. Valentino 2017-04-20